Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 24% ± 7% | |
fibroblast | 10 studies | 21% ± 5% | |
epithelial cell | 7 studies | 34% ± 15% | |
oligodendrocyte | 7 studies | 25% ± 7% | |
ciliated cell | 6 studies | 30% ± 11% | |
astrocyte | 6 studies | 29% ± 10% | |
macrophage | 6 studies | 23% ± 4% | |
glutamatergic neuron | 5 studies | 44% ± 24% | |
microglial cell | 5 studies | 22% ± 5% | |
adipocyte | 5 studies | 21% ± 4% | |
goblet cell | 5 studies | 26% ± 15% | |
smooth muscle cell | 5 studies | 16% ± 1% | |
B cell | 4 studies | 23% ± 6% | |
neuron | 4 studies | 26% ± 10% | |
myeloid cell | 4 studies | 22% ± 3% | |
abnormal cell | 4 studies | 20% ± 8% | |
GABAergic neuron | 4 studies | 43% ± 15% | |
oligodendrocyte precursor cell | 4 studies | 32% ± 8% | |
endothelial cell of lymphatic vessel | 4 studies | 19% ± 3% | |
mast cell | 4 studies | 19% ± 3% | |
interneuron | 4 studies | 37% ± 21% | |
pancreatic A cell | 3 studies | 34% ± 16% | |
CD4-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
retinal bipolar neuron | 3 studies | 18% ± 3% | |
myofibroblast cell | 3 studies | 19% ± 3% | |
pericyte | 3 studies | 19% ± 5% | |
retina horizontal cell | 3 studies | 24% ± 5% | |
lymphocyte | 3 studies | 21% ± 3% | |
type I pneumocyte | 3 studies | 16% ± 1% | |
connective tissue cell | 3 studies | 17% ± 1% | |
intestinal crypt stem cell | 3 studies | 17% ± 2% | |
basal cell | 3 studies | 39% ± 10% | |
transit amplifying cell | 3 studies | 24% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 2933.43 | 21 / 21 | 100% | 16.75 | 504 / 504 |
breast | 100% | 2742.20 | 459 / 459 | 100% | 25.19 | 1118 / 1118 |
esophagus | 100% | 2785.54 | 1445 / 1445 | 100% | 22.26 | 183 / 183 |
intestine | 100% | 2868.93 | 966 / 966 | 100% | 17.28 | 527 / 527 |
ovary | 100% | 2789.03 | 180 / 180 | 100% | 12.90 | 430 / 430 |
prostate | 100% | 2981.23 | 245 / 245 | 100% | 22.53 | 502 / 502 |
brain | 100% | 2298.08 | 2640 / 2642 | 100% | 19.71 | 705 / 705 |
thymus | 100% | 2734.70 | 653 / 653 | 100% | 18.42 | 604 / 605 |
lung | 100% | 2262.51 | 577 / 578 | 100% | 18.93 | 1155 / 1155 |
skin | 100% | 2918.25 | 1809 / 1809 | 100% | 15.52 | 471 / 472 |
uterus | 100% | 3101.26 | 170 / 170 | 100% | 16.57 | 458 / 459 |
kidney | 100% | 2317.90 | 89 / 89 | 100% | 19.02 | 898 / 901 |
stomach | 100% | 2347.07 | 359 / 359 | 100% | 18.99 | 285 / 286 |
liver | 100% | 1985.84 | 226 / 226 | 100% | 11.81 | 404 / 406 |
pancreas | 100% | 1884.37 | 328 / 328 | 99% | 16.15 | 177 / 178 |
adrenal gland | 100% | 2611.31 | 258 / 258 | 97% | 12.07 | 223 / 230 |
adipose | 100% | 2614.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2808.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.74 | 29 / 29 |
muscle | 100% | 1840.78 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2547.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.09 | 1 / 1 |
heart | 99% | 1561.24 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 11.57 | 78 / 80 |
peripheral blood | 82% | 1482.78 | 766 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0015031 | Biological process | protein transport |
GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
GO_0006906 | Biological process | vesicle fusion |
GO_0048219 | Biological process | inter-Golgi cisterna vesicle-mediated transport |
GO_0006891 | Biological process | intra-Golgi vesicle-mediated transport |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005801 | Cellular component | cis-Golgi network |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031201 | Cellular component | SNARE complex |
GO_0016020 | Cellular component | membrane |
GO_0005797 | Cellular component | Golgi medial cisterna |
GO_0030133 | Cellular component | transport vesicle |
GO_0005484 | Molecular function | SNAP receptor activity |
Gene name | GOSR1 |
Protein name | Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) (GOS-28) Golgi SNAP receptor complex member 1 |
Synonyms | GS28 |
Description | FUNCTION: Involved in transport from the ER to the Golgi apparatus as well as in intra-Golgi transport. It belongs to a super-family of proteins called t-SNAREs or soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor. May play a protective role against hydrogen peroxide induced cytotoxicity under glutathione depleted conditions in neuronal cells by regulating the intracellular ROS levels via inhibition of p38 MAPK (MAPK11, MAPK12, MAPK13 and MAPK14). Participates in docking and fusion stage of ER to cis-Golgi transport. Plays an important physiological role in VLDL-transport vesicle-Golgi fusion and thus in VLDL delivery to the hepatic cis-Golgi. . FUNCTION: Involved in transport from the ER to the Golgi apparatus as well as in intra-Golgi transport. It belongs to a super-family of proteins called t-SNAREs or soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor. May play a protective role against hydrogen peroxide induced cytotoxicity under glutathione depleted conditions in neuronal cells by regulating the intracellular ROS levels via inhibition of p38 MAPK (MAPK11, MAPK12, MAPK13 and MAPK14). Participates in docking and fusion stage of ER to cis-Golgi transport. Plays an important physiological role in VLDL-transport vesicle-Golgi fusion and thus in VLDL delivery to the hepatic cis-Golgi. . FUNCTION: Involved in transport from the ER to the Golgi apparatus as well as in intra-Golgi transport. It belongs to a super-family of proteins called t-SNAREs or soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor. May play a protective role against hydrogen peroxide induced cytotoxicity under glutathione depleted conditions in neuronal cells by regulating the intracellular ROS levels via inhibition of p38 MAPK (MAPK11, MAPK12, MAPK13 and MAPK14). Participates in docking and fusion stage of ER to cis-Golgi transport. Plays an important physiological role in VLDL-transport vesicle-Golgi fusion and thus in VLDL delivery to the hepatic cis-Golgi. . FUNCTION: Involved in transport from the ER to the Golgi apparatus as well as in intra-Golgi transport. It belongs to a super-family of proteins called t-SNAREs or soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor. May play a protective role against hydrogen peroxide induced cytotoxicity under glutathione depleted conditions in neuronal cells by regulating the intracellular ROS levels via inhibition of p38 MAPK (MAPK11, MAPK12, MAPK13 and MAPK14). Participates in docking and fusion stage of ER to cis-Golgi transport. Plays an important physiological role in VLDL-transport vesicle-Golgi fusion and thus in VLDL delivery to the hepatic cis-Golgi. . FUNCTION: Involved in transport from the ER to the Golgi apparatus as well as in intra-Golgi transport. It belongs to a super-family of proteins called t-SNAREs or soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor. May play a protective role against hydrogen peroxide induced cytotoxicity under glutathione depleted conditions in neuronal cells by regulating the intracellular ROS levels via inhibition of p38 MAPK (MAPK11, MAPK12, MAPK13 and MAPK14). Participates in docking and fusion stage of ER to cis-Golgi transport. Plays an important physiological role in VLDL-transport vesicle-Golgi fusion and thus in VLDL delivery to the hepatic cis-Golgi. . FUNCTION: Involved in transport from the ER to the Golgi apparatus as well as in intra-Golgi transport. It belongs to a super-family of proteins called t-SNAREs or soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor. May play a protective role against hydrogen peroxide induced cytotoxicity under glutathione depleted conditions in neuronal cells by regulating the intracellular ROS levels via inhibition of p38 MAPK (MAPK11, MAPK12, MAPK13 and MAPK14). Participates in docking and fusion stage of ER to cis-Golgi transport. Plays an important physiological role in VLDL-transport vesicle-Golgi fusion and thus in VLDL delivery to the hepatic cis-Golgi. . FUNCTION: Involved in transport from the ER to the Golgi apparatus as well as in intra-Golgi transport. It belongs to a super-family of proteins called t-SNAREs or soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein receptor. May play a protective role against hydrogen peroxide induced cytotoxicity under glutathione depleted conditions in neuronal cells by regulating the intracellular ROS levels via inhibition of p38 MAPK (MAPK11, MAPK12, MAPK13 and MAPK14). Participates in docking and fusion stage of ER to cis-Golgi transport. Plays an important physiological role in VLDL-transport vesicle-Golgi fusion and thus in VLDL delivery to the hepatic cis-Golgi. . |
Accessions | O95249 G5E9T8 ENST00000581721.5 B4DQA8 ENST00000427274.6 F6RU00 E9PCW1 ENST00000467337.6 [O95249-2] K7EJC8 ENST00000225724.9 [O95249-1] ENST00000537788.6 Q9BZZ3 ENST00000451249.7 ENST00000414833.2 |